Moderna COVID-19 vaccines have been suspended in Japan after the discovery of contaminants. It was reported that the Gunma prefectural government stated on Sunday, Aug. 29, that some foreign substances were found in the coronavirus vaccine made by the American biotech company Moderna.
The vaccine was tested after a series of reports regarding contaminants in the product have emerged in Japan. According to Kyodo News, a blackish foreign matter was detected during the inspections prior to the vaccination schedules. The pollutant was said to be less than 0.5 millimeters in size.
The vials have different lot numbers from the initial three lots that were already suspended last week. The Moderna vaccine lots with the contaminants were found last Thursday and Saturday in Okinawa. The vials were said to have black and pink substances in them.
Unfortunately, around 4,500 people were inoculated with the possibly contaminated Moderna shots. The affected lots were used in the vaccinations for over three days last week in Gunma. The territory is the seventh to report about the foreign substance in the Moderna vaccine after Okinawa, Aichi, Gifu, Saitama, Tokyo, and Ibaraki.
The country’s Health, Labor, and Welfare Ministry said that rubber pieces may have dropped into the vials when the needle syringe was punctured into the rubber to take out content. Other than the foreign matter, there is no issue with the quality of the vaccine.
Now, while some experts say that it is safe to continue with the inoculations using Moderna vaccines as the quality is not affected, an investigation has been launched with regards to the death of two Japanese citizens who received the Moderna jab. They were said to have passed away just days after their vaccination.
CNN News reported that the authorities are investigating if the deaths have links to the contaminated Moderna vaccines. As of this time, there is no conclusion yet, but the experts are continuing their assessment to determine the safety of the shots.
Takeda Pharmaceutical Company said in a statement that was released last Saturday, "Currently, no link has been confirmed between these deaths and the Moderna vaccine, but we believe it is important to carry out a formal probe to investigate the matter further."


Xiaomi's AI Model "Hunter Alpha" Mistaken for DeepSeek's Next Release
EA's $15B Debt Offering Draws $25B in Investor Demand Amid Credit Market Turmoil
Micron Technology Beats Q2 Earnings Estimates, Issues Strong AI-Driven Outlook
BOJ Holds Interest Rates Steady Amid Middle East Uncertainty
Asian Markets Mixed as Oil Volatility and Inflation Fears Weigh on Sentiment
Trump Signals End of U.S. Military Campaign Against Iran as Markets Rally
Gold Prices Stabilize but Head for Worst Weekly Drop in Six Years Amid Iran War Inflation Fears
Virgin Australia Adjusts Fares Amid Rising Aviation Costs and Middle East Tensions
Elon Musk Confirms SpaceX, xAI, and Tesla Will Continue Large-Scale Nvidia Chip Orders
FEMSA Cuts Jobs at Spin Fintech Unit, Refocuses Strategy on Oxxo Stores
Microsoft Eyes Legal Action as Amazon-OpenAI Deal Threatens Azure Exclusivity
GE Vernova and Hitachi's $40 Billion SMR Investment Signals a New Era for U.S. Nuclear Energy
Apple Defies China's Smartphone Slump with Strong Early 2026 Sales
J.P. Morgan Now Expects Two ECB Rate Hikes Amid Inflation Pressures
Tesla FSD EU Approval Delayed to April 10 as RDW Completes Final Review
FCC Approves $3.54B Nexstar-Tegna Merger, Waiving Broadcast Ownership Cap
S&P 500 Rebounds After Netanyahu's Statements on Iran's Military Setbacks 



